Description
LBR-101, PF-04427429, RI-307, RN-307, TEV-48125, fremanezumab-vfrm, CAS: 1655501-53-3
Targets
CCP, PDN-21, CALCA, Calcitonin carboxyl-terminal peptide, Calcitonin, CALC1, Calcitonin gene-related peptide II, CALCB, Calcitonin gene-related peptide 2, Beta-CGRP, CALC2, CGRP-II, Beta-type CGRP
Isotype/Mimetic
IgG2-kappa
Animal-Derived Biomaterials Used
None
Sequence Available
No
Original Discovery Method
Unknown
Original Discovery Information Provided On Datasheet
No
Antibody/Binder Origins
Unknown discovery source/method, In vitro recombinant expression